OTC · Biotechnology

BioStem Technologies, Inc. (BSEM) Stock

$2.55 -3.37% OTC: BSEM Healthcare

Valuation

MetricValue
Price$2.55
Market Cap$43.33M
P/E Ratio-1.66
P/B Ratio1.73
P/S Ratio-0.78
EPS (TTM)$-0.39
52-Week High$8.40
52-Week Low$2.25
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-76.13%
ROA-57.95%
ROCE-84.50%
Gross Margin128.16%
Operating Margin78.38%
Net Margin46.91%
Debt/Equity0.04
Current Ratio1.14

Annual Financials (USD)

Metric20212022202320242025
Revenue$4.0M$7.0M$17.0M$302.0M$47.0M
Operating Profit$-2.0M$-5.0M$-8.0M$31.0M$-1.0M
Net Profit$-1.0M$-7.0M$-8.0M$32.0M$-7.0M
EPS$-0.15$-0.63$-0.62$1.47$-0.39
Op Margin-37.0%-68.1%-46.6%10.3%-1.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$3.0M$3.0M$15.0M$140.0M$50.0M
Total Liabilities$8.0M$7.0M$16.0M$100.0M$11.0M
Cash$0$1.0M$0$23.0M$30.0M
Borrowings$5.0M$5.0M$5.0M$4.0M$3.0M

Latest News

BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission GlobeNewswire · Jul 10, 2026 BioStem Technologies Announces Issuance of Four U.S. Design Patents Covering Fenestrated Human Placental Allograft Technologies ACCESS Newswire · Jul 8, 2026 BioStem Technologies to Present at the Planet MicroCap Las Vegas 2026 Conference GlobeNewswire · Jun 10, 2026 BioStem Technologies Expands Board with Three Appointments as Nasdaq Uplisting Remains a Key Objective (BSEM) InvestorsHub · Jun 9, 2026 BioStem Technologies Announces Appointment of Three New Members to its Board of Directors GlobeNewswire · Jun 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$0$-3.0M$24.0M$10.0M
Investing Cash Flow$0$-1.0M$0$-2.0M$-5.0M
Financing Cash Flow$0$0$2.0M$0$0
Net Cash Flow$0$0$-1.0M$23.0M$7.0M
Free Cash Flow$0$0$-4.0M$24.0M$7.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.02
EV / EBITDA-1.87
FCF Yield-18.87%
Quick Ratio0.76
Interest Coverage0.00
Return 1Y-66.19%
Return 3Y129.14%
Return 5Y—

Ownership

Insiders Held21.95%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATGGFActinogen Medical Limited $0.00 — -7.07 $2.97M 0.00%
CLTEFClara Technologies Corp. $0.06 -91.43% -23.94 $3.60M 0.00%
IUGNFImugene Limited $0.10 +0.00% -0.40 $41.60M 0.00%
MDXHFMedX Health Corp $0.04 +0.00% -3.20 $14.10M 0.00%
MSCLFSatellos Bioscience Inc. $6.25 +11.81% -1.75 $96.62M 0.00%

About BioStem Technologies, Inc.

BioStem Technologies, Inc. is headquartered in US.

BioStem Technologies, Inc. (BSEM) stock trades at $2.55 with a market capitalization of $43.33M. The stock is valued at a price-to-earnings (P/E) ratio of -1.66, price-to-book of 1.73, price-to-sales of -0.78. Over the past 52 weeks the stock has ranged between $2.25 and $8.40, and currently trades 69.6% below its 52-week high.

On profitability, BioStem Technologies, Inc. generates a return on equity (ROE) of -76.13%, return on capital employed of -84.50%, an operating margin of 78.38%, a net profit margin of 46.91%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1174.49 +0.42% JNJ Johnson & Johnson $261.01 +1.76% ABBV AbbVie Inc. $277.37 +1.82% MRK Merck & Company, Inc. Common Stock (new) $145.82 +2.42% UNH UnitedHealth Group Incorporated Common Stock (DE) $378.12 +1.93% NVS Novartis AG $143.26 +0.10% AZN AstraZeneca PLC $159.37 +0.37% TMO Thermo Fisher Scientific Inc $659.71 +1.19% AMGN Amgen Inc. $415.88 +2.07% GILD Gilead Sciences, Inc. $151.29 +2.85% ABT Abbott Laboratories $99.18 +0.70% NVO Novo Nordisk A/S $38.39 +0.54%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides